1Liang K, Ang KK, Milas L, et al. The epidermal growth factor receptor mediates radioresistance[J]. Int J Radiat Oncol Biol Phys, 2003, 57(1): 246-254.
2Barker FG 2nd, Simmons ML, Chang SM, et al. EGFR overexpression and radiation response in glioblastoma multiforme [J]. Int J Radiat Oncol Biol Phys, 2001, 51(2) : 410-418.
3Gupta AN, McKenna WG, Weber CN, et al. Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction[J]. Clin Cancer Res, 2002. 8(3) : 885-892.
4Roberg K, Jonsson AC, Grenman R, et al. Radiotherapy response in oral squamous carcinoma cell lines: evaluation of apoptotic proteins as prognostic factors[J]. Head Neck, 2007, 29(4) : 325-334.
5Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation[J]. Int J Radiat Oncol Biol Phys, 2001, 49(2) : 427-433.
6Nasu S, Ang KK, Fan Z, et al. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability[J]. Int J Radiat Oncol Biol Phys, 2001, 51 (2) : 474-477.
7Feng FY, Lopez CA, Norm olle DP, et al. Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo [J]. Clin Cancer Res, 2007, 13(8): 2512-2518.
8Nakata E, Hunter N, Mason K, et al. C225 Antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy[J]. Int J Radiation Oncology Biol Phys, 2004, 59(4): 1163-1173.
10Krause M, Ostermann G, Petersen C, et al. Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation[J]. Radiother Oncol, 2005, 76 (2) : 162-167.
3Dy KG, Adjei AA. Novel targets for lung cancer therapy. Part Ⅰ[J]. J Clin Oncol, 2002, 20(12) : 2881-2894.
4Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in biology and treatment of cancer[ J ]. Clin Oncol, 2003, 21 (14) : 2787-2799.
5Balin-Gauthier D, Delord JP, Rochaix P, et cd. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR[J]. Cancer Chem Pharmacol, 2006, 57(6) : 709-718.
6Liang K, Ang KK, Miles L, et cd. The epidermal growth factor receptor mediates radiotherapy [ J ]. Int J Radiat Oncol Biol Phys,2003, 57 ( 1 ) : 246-254.
7Eller JL, Longo SL, Kyle MM, et al. Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo[ J]. Neurosurgery, 2005, 56( 1 ) : 155-162.
8Raben D, Helfrich B, Chan DC, et al. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer[ J ]. Clin Cancer Res, 2005, 11 (2 Pt1) : 795-805.
9Huang SM, Bock JM, Harari PM, et al. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck[J]. Cancer Res, 1999, 59(8): 1935-1940.
10Huang SM, Harari PM. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis[J]. Clin Cancer Res, 2000, 6(6): 2166-2174.
